{"id":"W4225402038","doi":"10.1101/2022.04.30.22270885","title":"Dopamine D <sub>1</sub> agonist effects in late-stage Parkinson’s disease","year":2022,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; National Institute of Nursing Research; Penn State College of Medicine; University of Oxford; Weston Brain Institute; Boston Scientific Corporation; Michael J. Fox Foundation for Parkinson's Research; Johns Hopkins University; Pennsylvania State University; University of Pennsylvania; Biogen; Patient-Centered Outcomes Research Institute; Office of Behavioral and Social Sciences Research; Bristol-Myers Squibb; Pfizer; National Institute on Aging; Alzheimer's Association; National Institutes of Health; Medtronic; U.S. Department of Defense","keywords":"Levodopa; Carbidopa; Psychology; Medicine; Dopamine agonist; Clinical Global Impression; Physical therapy; Disease; Parkinson's disease; Physical medicine and rehabilitation; Clinical psychology; Dopamine; Internal medicine; Dopaminergic; Placebo","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008321707,0.0002618271,0.0004510719,0.0001486514,0.0001138335,0.0002201256,0.0001384194,0.0002360066,0.0008798628],"category_scores_gemma":[0.0005953872,0.00008203072,0.0002300753,0.00008202321,0.0001573698,0.0001471976,0.00009439526,0.0003234408,0.00009036626],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001790445,"about_ca_system_score_gemma":0.0001738948,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003251102,"about_ca_topic_score_gemma":0.001660463,"domain_scores_codex":[0.9998017,0.0001169665,0.00002915885,0.00001482084,0.00002077403,0.00001664717],"domain_scores_gemma":[0.9996406,0.0001436624,0.0001096173,0.00001555022,0.00003330074,0.00005733285],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1685937,0.009438817,0.09870842,0.003522618,0.001057671,0.001336661,0.0005350051,0.001360399,0.2298029,0.0002181977,0.001755436,0.4836702],"study_design_scores_gemma":[0.01951856,0.463879,0.4602793,0.000416508,0.001300778,0.003214458,0.0003472537,0.002115799,0.04046464,0.000326325,0.00809277,0.00004456624],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9889728,0.009700566,0.0001871573,0.00007383866,0.00002361275,0.0001032607,0.0001295692,0.00001075167,0.0007983847],"genre_scores_gemma":[0.9975129,0.001688319,0.0003320837,0.00009673555,0.00002667328,0.0000316363,0.0001114565,0.000001125262,0.0001990507],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0008798628,"threshold_uncertainty_score":0.004400969,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01669001410149306,"score_gpt":0.2645335934730132,"score_spread":0.2478435793715201,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}